Cleanis’ award-winning CareBag® solution is a first-to-market innovation that simplifies the unpleasant task of patient waste management and helps decrease the spread of infection. In fact, in 2020, the French Ministry of Health officially recommended that hospitals use the CareBag® solution to stem the spread of COVID-19.1
1.METHODOLOGY GUIDE : “PREPARATION AGAINST THE COVID-19 EPIDEMIC: Healthcare facilities, ambulatory medicine and medico-social facilities”. Ministry of Solidarity and Health of the French Republic (February 20th, 2020).
Hospitals and the Spread of Infection
Even the strictest hospital manual cleaning protocols cannot prevent the spread of infections. Studies show that up to 50%2 of patient environments may remain infected after a routine cleaning. Microorganisms can remain present in the air for up to seven days,3 making these unclean spaces a hazard for patients, caregivers, and families.
2.Peters, A., Otter, J., Moldovan, A. et al. Keeping hospitals clean and safe without breaking the bank; summary of the Healthcare Cleaning Forum 2018. Antimicrob Resist Infect Control 7, 132 (2018). https://doi.org/10.1186/s13756-018-0420-3 3. Fernstrom A., Goldblatt M., “Aerobiology and Its Role in the Transmission of Infectious Diseases.” Journal of Pathogens vol.2013.
Multiple clinical studies have found that using CareBag®, combined with other best hygiene practices, is a proven method of reducing the spread of infection. According to a clinical study of a seven-hospital system, the CareBag® solution helped reduce C. diff by 30%.4
4. Yaney, Eileen MS, CIC; Filippone, Christine DNP, MSN, CIC, et all. ”Clostridium difficile Reduction Challenges in a Multi-System Hospital System.” RWJ Barnabas Health. Poster. 2016.
500+ hospital CareBag® users overwhelmingly said that Cleanis’ flagship solution helped improve their workday.5
According to a clinical study, even the number of steps required to care for patient waste is reduced with the use of CareBag®. The number of steps required for caring for an infectious patient was reduced from 20 to nine.6
5. Confidential responses to Cleanis survey on usage. 2019 – 2021. 6.E. Vitale, B.Sc. MLT, CIC. “Safer “Pan Handling” to Reduce the Rates of Vancomycin Resistant Enterococci.” Poster.
The average hospital has 63 7,8 healthcare-associated C. diff cases per year at a cost of $34,157 9 per case. The estimated annual cost per facility is $2,151,891.
A small investment in CareBag® products saves the average hospital between $635k and $1.065M every year.10